In addition, the knockdown of Axin also restored the β-catenin protein levels and the cell viability of CRC cells treated with FK866; this further validates that the inhibition of NAMPT modulates Wnt/β-catenin signaling. The gene discussed is AXIN1; the disease is colorectal carcinoma.